Figure 2.
![Effect of danicopan on laboratory markers. Mean (and standard deviation [SD]) change from baseline (BL) for Hgb (primary end point) (A), reticulocytes (B), total bilirubin (C), direct bilirubin (D), LDH (E), and FACIT-Fatigue score (F). P values represent change from baseline to week 24.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/138/20/10.1182_blood.2021011388/7/bloodbld2021011388f2.png?Expires=1736050074&Signature=dJCb9aNXgI18~lM-C2wFQAQV44dqwG40qEfMpSP952zLDveV5vZ7ALY3ibBWq6JhYrOx76ZUguepoFXn8XqQyV5jCB~el7mw1aK0wtsdP9pHQW~7VcEQCoj5tLuIfIPmzda2t53jptwnghpRvSAhbP7450dqIfe9zqs76vBTraYG9VvJGX8w5lF4qlk8oWsmvq6aR~i7FHB20ZDwTK543gXbirOLtoORnsyDxr99r1Qz-4F-pLbjf9oBhEe8xrkcO0x4agw8TESov1unY391FZeiyaXqOsBe5mPqORdouaqvHuIYCowWvYe2PwSWwO6ohB9LVEAUp3rHALc~2ofo8A__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Effect of danicopan on laboratory markers. Mean (and standard deviation [SD]) change from baseline (BL) for Hgb (primary end point) (A), reticulocytes (B), total bilirubin (C), direct bilirubin (D), LDH (E), and FACIT-Fatigue score (F). P values represent change from baseline to week 24.